Second trimester markers of aneuploidy

Bailliere's Best Practice and Research in Clinical Obstetrics and Gynaecology

Volumn 14, Issue 4, 2000, Pages 595-610

  Ogle, Robert F ^a,b  

^a LIVERPOOL HOSPITAL   (Australia)

^b UNIVERSITY OF NEW SOUTH WALES   (Australia)

Author keywords

Aneuploidy; Down Syndrome; Screening marker; Ultrasound

Indexed keywords

ANEUPLOIDY; BONE DEFECT; BRACHYCEPHALY; BRAIN MALFORMATION; BRAIN VENTRICULITIS; CHOROID PLEXUS TUMOR; DISEASE ASSOCIATION; DISEASE MARKER; DOWN SYNDROME; ECHOGRAPHY; FETUS DISEASE; GENETIC COUNSELING; HUMAN; MATERNAL AGE; ORGAN SIZE; PHALANX HYPOPLASIA; PRENATAL SCREENING; PRIORITY JOURNAL; REVIEW; RISK ASSESSMENT; SECOND TRIMESTER PREGNANCY; TRISOMY 13; TRISOMY 18; TRISOMY 21;

EID: 0033796637     PISSN: 15216934     EISSN: None     Source Type: Journal    
DOI: 10.1053/beog.2000.0099     Document Type: Article

References (142)

1. Chromosome abnormalities: Prevalence, risk and recurrences
2. The frequency of 47, + 21, 47, + 18 and 47, + 13 at the uppermost extremes of maternal ages: Results on 56 094 fetuses studied prenatally and comparison with data on livebirths
3. Maternal age specific rates for chromosome aberrations, factors influencing them: Report of collaborative study on 52 965 amniocenteses
4. The selective miscarriage of Down syndrome from 10 weeks of pregnancy
5. Maternal age and gestational age-specific rates for chromosomal defects
6. Prenatal sonographic findings of Down syndrome: Review of 94 cases
7. Sonographic identification of second trimester fetuses with Down syndrome
8. The second trimester fetus with Down syndrome: Detection using sonographic features
9. The sonographic detection of trisomies 13, 18 and 21
10. Sonographic detection of fetuses with trisomies 13 and 18: Accuracy and limitations
11. Ultrasonographically detectable markers of fetal chromosomal abnormalities
12. Prenatal karyotype on malformed fetuses
13. Chromosomal abnormalities: How much can we predict by ultrasound examination in low risk pregnancies?
14. Effectiveness of routine ultrasonography in detecting fetal structural abnormalities in a low risk population
15. Routine radiographer screening for fetal abnormalities by ultrasound in an unselected population
16. Role of prenatal ultrasonography with positive screen for Down syndrome on the basis of maternal serum markers
17. Prenatal screening for Down syndrome
18. Adjusting the risk of trisomy 21 on the basis of second trimester ultrasonography
19. Identification of second trimester fetuses with autosomal trisomy by use of a sonographic scoring index
20. Age adjusted ultrasound risk assessment for fetal Down syndrome during the second trimester: Description of the method of analysis of 142 cases
21. Minimal fetal renal pyelectasis
22. Fetal pyelectasis: A possible association with Down syndrome
23. Fetal pyelectasis and Down syndrome: Is genetic amniocentesis warranted?
24. A prospective study of the association between isolated fetal pyelectasis and chromosomal abnormalities
25. Minimal hydronephrosis in the fetus: Clinical significance and implications for management
26. The association of aneuploidy and mild fetal pyelectasis in a selected population: The results of a multicentre study
27. Fetal renal defects: Associated malformations and chromosomal defects
28. Isolated fetal pyelectasis: Assessment of risk for prenatal uropathy and Down syndrome
29. Fetal pyelectasis: Is it always 'physiologic'?
30. Effect of routine screening for Down syndrome on the significance of isolated fetal hydronephrosis
31. Assessment of risks
32. The prenatal diagnosis of transient cysts of the fetal choroid plexus
33. Prenatal diagnosis of cysts of the fetal choroid plexus
34. Prospective study on trisomy 18 and fetal choroid plexus cysts
35. Fetal choroid plexus cysts: A report of 100 cases
36. Fetal lateral ventricle choroid plexus cysts: The dilemma of amniocentesis
37. Fetal choroid plexus cysts: A prospective study and review of the literature
38. Sonographically detected fetal choroid plexus cysts
39. The significance of choroid plexus cysts in fetuses at 18-20 weeks. An indication for amniocentesis?
40. Depistage antenatal des kystes des plexus choroides
41. Isolated choroid plexus cysts - The need for routine offer of karyotyping
42. Clinical significance of choroid plexus cysts
43. Choroid plexus cysts - Association with trisomy: Prospective review of 16 059 patients
44. Isolated choroid plexus cysts and aneuploidy
45. Isolated choroid plexus cysts and association with fetal aneuploidy in an unselected population
46. Choroid plexus cysts in the fetus: A benign anatomic variant or pathological entity? Report of 41 cases and review of the literature
47. Fetal choroid plexus cysts: Prevalence, clinical significance, and sonographic appearance
48. The clinical significance of prenatally diagnosed choroid plexus cysts
49. A sonographic and karyotypic study of second trimester fetal choroid plexus cysts
50. Fetal choroid plexus lesions. Relationship of antenatal sonographic appearance to clinical outcome
51. Choroid plexus cysts and chromosomal defects
52. Fetal choroid plexus cysts in the second trimester of pregnancy: A cause for concern
53. Chromosomal findings in fetuses with prenatally diagnosed cysts of the choroid plexus
54. Isolated fetal choroid plexus cyst(s): An indication for amniocentesis
55. Isolated fetal choroid plexus cysts and trisomy 18: A review and meta-analysis
56. Isolated fetal choroid plexus cysts and karyotype analysis: Is it necessary?
57. Isolated choroid plexus cysts in the second trimester: Is amniocentesis really indicated?
58. Fetal choroid plexus cysts and trisomy 18: Assessment of risk based on ultrasound findings and maternal age
59. Is genetic amniocentesis warranted when isolated choroid plexus cysts are found?
60. Aneuploidy at 15-20 weeks gestation in fetuses with isolated choroid plexus cysts
61. Choroid plexus cysts: Amniocentesis versus multiple marker screening and ultrasound detection of trisomy 18
62. Congenital anomalies in karyotypically normal fetuses with choroid plexus cysts
63. Fetal choroid plexus cysts: Beware the smaller cyst
64. Fetal choroid plexus cysts: An independent risk factor for chromosomal anomalies
65. Antenatal diagnosis of choroid plexus cysts: Suggested management
66. The significance of choroid plexus cysts in an unselected population: Results of a multicentre study
67. Disappearance of fetal choroid plexus cysts during the second trimester in cases of chromosomal abnormality
68. Sonographic detection of fetuses with trisomies 13 and 18: Accuracy and limitations
69. In utero thickening of the chordae tendinae. A cause of intracardiac echogenic foci
70. Natural history of echogenic foci within ventricles of the fetal heart
71. Prevalence of fetal left ventricular hyperechogenic foci in a low risk population
72. The left ventricular echogenic focus: A normal finding
73. Small echogenic foci of the fetal cardiac ventricle: A benign sonographic finding?
74. Echogenic intracardiac focus: A sonographic sign for fetal Down syndrome
75. Prospective evaluation of the antenatal incidence and postnatal significance of the fetal echogenic cardiac focus: A case-control study
76. Prenatal ultrasonographic diagnosis of fetal heart echogenic foci: No correlation with Down syndrome
77. Significance of fetal intracardiac foci to trisomy 21: A prospective sonographic study of high-risk pregnant women
78. Isolated intraventricular echogenic foci or 'golf balls': Is karyotyping for Down syndrome indicated?
79. The value of echogenic foci ('golf balls') in the fetal heart as a marker of chromosomal abnormalities
80. Early prenatal diagnosis of hydrocephalus
81. The karyotype of fetuses with anomalies detected by second trimester ultrasonography
82. Isolated mild ventriculomegaly: Associated karyotypic abnormalities and in utero observations
83. Mild idiopathic lateral cerebral ventricular dilatation in utero: Sonographic evaluation
84. Mild fetal lateral cerebral ventriculomegaly: Clinical course and outcome
85. Fetal mild idiopathic lateral ventriculomegaly: Is there a correlation with fetal trisomy?
86. Isolated mild fetal cerebral ventriculomegaly: Clinical course and outcome
87. Distal lateral ventricular atrium: Reevaluation of normal range
88. The developmental outcome of children with antenatal mild isolated ventriculomegaly
89. Sonographic evaluation of the normal developmental anatomy of the fetal cerebral ventricles: II. The atria
90. The clinical significance of fetal isolated cerebral borderline ventriculomegaly: Report of 31 cases and review of the literature
91. Prenatal diagnosis and follow up of 14 cases of unilateral ventriculomegaly
92. Is fetal hyperechoeic bowel on second trimester sonogram an indication for amniocentesis?
93. Echogenic fetal bowel during the second trimester: Clinical importance
94. Meconium ileus in cystic fibrosis fetuses
95. The clinical significance of increased echogenecity in the fetal abdomen
96. Intrauterine cytomegalovirus infection presenting as fetal meconium peritonitis
97. Meconium peritonitis: Prenatal sonographic findings and their clinical significance
98. Sonographically detected hyperechoeic fetal bowel: Significance and implications for pregnancy management
99. Second trimester echogenic bowel and intra-amniotic bleeding: Association bowel echogenecity and amniotic fluid spectrophotometry at 410 nm
100. Prognostic implications of fetal echogenic bowel
101. A sonographic sign for the detection in the second trimester of the fetus with Down syndrome
102. Sonographically measured nuchal skinfold thickness as a screening tool for Down syndrome: Results of a prospective clinical trial
103. Thickened nuchal fold in fetuses not at risk for aneuploidy
104. Routine measurement of nuchal thickness in the second trimester
105. Down syndrome: Sonographic sign for diagnosis in the second trimester fetus
106. Prenatal sonographic findings of Down syndrome: Review of 94 cases
107. The association between an abnormal nuchal skin fold, trisomy 21, and ultrasound abnormalities identified during the second trimester of pregnancy
108. Optimal nuchal skin-fold thresholds based on gestational age for prenatal detection of Down syndrome
109. Ultrasonographic measurement of fetal nuchal skin to screen for chromosomal abnormalities
110. Prospective multicentre study of second trimester nuchal skinfold thickness in unaffected and Down syndrome pregnancies
111. Sonographic measurement of nuchal skinfold thickness for detection of Down syndrome in the second trimester fetus: A multicentre prospective study
112. Early midtrimester fetal nuchal thickness: Effectiveness as a marker of Down syndrome
113. Ultrasound fetal femur length measurement in the screening for Down syndrome
114. Fetal biometry as a screening tool for the detection of chromosomally abnormal pregnancies
115. Comparison of humerus length with femur length in fetuses with Down syndrome
116. Fetal femur length to detect trisomy 21. A reappraisal
117. The efficacy of fetal sonographic biometry in Down syndrome screening
118. Femur length shortening in the detection of Down syndrome: Is prenatal screening feasible?
119. Femur length in the ultrasound prediction of trisomy 21 and other chromosomal abnormalities
120. Fetal femur length to detect Down syndrome
121. Humerus and femur length shortening in the detection of Down syndrome
122. Humerus and femur length in fetuses with Down syndrome
123. Combining humerus and femur length for improved ultrasonographic identification of pregnancies at increased risk for trisomy 21
124. Adjusting the risk for trisomy 21 by a simple method using fetal long-bone biometry
125. Limited effectiveness of femur and humeral shortening as markers of Down syndrome in early midtrimester fetuses
126. Biparietal diameter/femur length ratio, cephalic index, and femur length measurements: Not reliable screening techniques for Down syndrome
127. Efficacy of the biparietal diameter/femur length ratio to detect Down syndrome in patients with an abnormal biochemical screen
128. Humeral shortening in second trimester fetuses with Down syndrome
129. Mongolism in newborn infants. An examination of the criteria for recognition and some speculations on pathogenetic activity of the chromosomal abnormality
130. Hypoplasia of the middle phalanx of the fifth digit: A feature of the second trimester fetus with Down syndrome
131. Fetal breasts in normal and Down syndrome fetuses
132. Fetal cephalometry by ultrasound as a screening procedure for the prenatal detection of Down syndrome
133. Fetuses with Down syndrome have disproportionately shortened frontal lobe dimensions on ultrasonographic examination
134. Fetal ear measurements in the prenatal detection of trisomy 21
135. Fetal ear length
136. Ear length in second trimester aneuploid fetuses
137. The role of reduced ear size in the prenatal detection of chromosomal abnormalities
138. Fetal transcerebellar diameter in Down syndrome
139. Prenatal detection of the separation of the great toe, toe syndactyly and large bilateral choroid plexus cysts in a fetus with trisomy 18
140. Separation of the great toe in fetuses with Down syndrome
141. The second trimester fetal iliac angle as a sign of Down syndrome
142. Can fetal iliac bone measurement be used as a marker for Down syndrome screening?